Literature DB >> 19002129

Routine screening for germline RET mutations is recommended for all patients with medullary thyroid cancer.

Diana L Learoyd1, Bruce G Robinson.   

Abstract

Entities:  

Year:  2008        PMID： 19002129     DOI： 10.1038/ncpendmet1020

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN： 1745-8366


× No keyword cloud information.
  7 in total

1.  Lessons learned from the management of a rare genetic cancer.

Authors:  Gilbert J Cote; Robert F Gagel
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

Review 2.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

3.  The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.

Authors:  C Eng; D Clayton; I Schuffenecker; G Lenoir; G Cote; R F Gagel; H K van Amstel; C J Lips; I Nishisho; S I Takai; D J Marsh; B G Robinson; K Frank-Raue; F Raue; F Xue; W W Noll; C Romei; F Pacini; M Fink; B Niederle; J Zedenius; M Nordenskjöld; P Komminoth; G N Hendy; L M Mulligan
Journal:  JAMA       Date:  1996-11-20       Impact factor: 56.272

4.  Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma.

Authors:  N Wohllk; G J Cote; M M Bugalho; N Ordonez; D B Evans; H Goepfert; S Khorana; P Schultz; C S Richards; R F Gagel
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

5.  RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.

Authors:  Rossella Elisei; Cristina Romei; Barbara Cosci; Laura Agate; Valeria Bottici; Eleonora Molinaro; Mariangela Sculli; Paolo Miccoli; Fulvio Basolo; Lucia Grasso; Furio Pacini; Aldo Pinchera
Journal:  J Clin Endocrinol Metab       Date:  2007-09-25       Impact factor: 5.958

6.  Familial prevalence and age of RET germline mutations: implications for screening.

Authors:  Andreas Machens; Henning Dralle
Journal:  Clin Endocrinol (Oxf)       Date:  2008-07-01       Impact factor: 3.478

7.  Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors.

Authors:  Francesca Carlomagno; Teresa Guida; Suresh Anaganti; Giancarlo Vecchio; Alfredo Fusco; Anderson J Ryan; Marc Billaud; Massimo Santoro
Journal:  Oncogene       Date:  2004-08-12       Impact factor: 9.867
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.